References
- Tegerstedt G, Maehle-Schmidt M, Nyren O, Hammarstorm M. Prevalence of symptomatic pelvic organ prolapse in a Swedish population. Int Urogynecol J Pelvic Floor Dysfunct. 2005; 16:497-503.10.1007/s00192-005-1326-1
- Woodman PJ, Swift SE, O’Boyle AL, Valley MT, Bland DR, Kahn MA, et al. Prevalence of severe pelvic organ prolapse in relation to job description and socioeconomic status: a multicenter crosssectional study. Int Urogynecol J Pelvic Floor Dysfunct. 2006; 17:340-5.10.1007/s00192-005-0009-2
- Chuenchompoonut V, Bunyavejchevin S, Wisawasukmongchol W, Taechakraichana N. Prevalence of genital prolapse in Thai menopausal women (using new standardization classification). J Med Assoc Thai. 2005; 88:1-4.15960208
- Jones KA, Harmanli O. Pessary use in pelvic organ prolapse and urinary incontinence. Rev Obstet Gynecol. 2010; 3:3-9.20508777
- Cundiff GW, Weidner AC, Visco AG, Bump RC, Addison WA. A survey of pessary use by members of the American Urogynecologic Society. Obstet Gynecol. 2000; 95:931-5.10831995
- Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J obstet Gynecol. 2004; 190:1025-9.10.1016/j.ajog.2003.10.71115118635
- Manchana T. Ring pessary for all pelvic organ prolapse. Arch Gynecol Obstet. 2011; 284:391-5.2084811610.1007/s00404-010-1675-y
- Lamers BHC, Broekman BMW, Milani AL. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J. 2011; 22: 637-44.2147244710.1007/s00192-011-1390-7
- Manchana T, Bunyavejchevin S. Impact on quality of life after ring pessary use for pelvic organ prolapse. Int Urogynecol J. 2012; 23:873-7.10.1007/s00192-011-1634-622222673
- Barber MD, Walters MD, Cundiff GW. Responsiveness of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ) in women undergoing vaginal surgery and pessary treatment for pelvic organ prolapse. Am J Obstet Gynecol. 2006; 194:1492-8.10.1016/j.ajog.2006.01.07616647933
- Patel M, Mellen C, O’Sullivan DM, LaSala CA. Impact of pessary use on prolapse symptoms, quality of life, and body image. Am J Obstet Gynecol. 2010; 202: 499e1-4.10.1016/j.ajog.2010.01.019
- Abdool Z, Thakar R, Sultan AH. Prospective evaluation of outcome of vaginal pessaries versus surgery in women with symptomatic pelvic organ prolapse. Int Urogynecol J. 2011; 22:273-8.2116117910.1007/s00192-010-1340-9
- Price N, Jackson S, Avery K, Brookes S, Abrams P. Development and psychometric evaluation of the ICIQ Vaginal symptoms Questionnaire: the ICIQVS. BJOG. 2006; 113:700-12.10.1111/j.1471-0528.2006.00938.x16709214
- Singer AJ, Thode JR HC. Determination of the minimal clinically significant difference on a patient visual analog satisfaction scale. Acad Emerg Med. 1998; 5: 1007-11.10.1111/j.1553-2712.1998.tb02781.x
- Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JOL, Klarskov P, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996; 175:10-7.869403310.1016/S0002-9378(96)70243-0
- Tenfelde S, Tell D, Thomas TN, Kenton K. Quality of life in women who use pessaries for longer than 12 months. Female Pelvic Med Reconstr Surg. 2015; 21: 146-9.10.1097/SPV.000000000000015425521465
- Sitavarin S, Wattanayingcharoenchai R, Manonai J, Sarit-apirak S, Chittacharoen A. The characteristics and satisfaction of the patients using vaginal pessaries. J Med Assoc Thai. 2009; 92:744-7.19530578